US-COHORT ANALYSIS: FIVE-YEAR OUTCOMES OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER PRESCRIBED ANTIFIBROTICSGlenn Eiger, RAUL LEGUIZAMON, Andrew Geller et al.|CHEST Journal|2025Cited by 0